Mirador Analytics has launched an online version of its prevalence-based Asset Evaluation Tool.

If you are engaged in New Product Planning, Drug Development, Launch Planning, Portfolio Prioritization, Life Cycle Management or working towards a specific transaction (e.g. license and/or investment), Mirador is positioned to advise you on how the Asset Evaluation Tool could support you through these processes. [Read more…]